Literature DB >> 12772523

Hepatic resection for colorectal metastases to the liver: The National Cancer Centre/Singapore General Hospital experience.

C S C Teh1, L L P J Ooi.   

Abstract

OBJECTIVE: To review and evaluate trends for short and long-term outcomes of patients who have undergone liver resection for colorectal metastases in a single institution over a period of 7 years.
MATERIALS AND METHODS: A retrospective review and analysis of clinicopathologic data and outcome of potentially curative liver resection for colorectal metastases in a series of 96 patients from January 1994 to December 2001 was done. Data were statistically analysed. Perioperative mortality, morbidity, overall survival and disease-free survival rates were reported.
RESULTS: A total of 96 patients underwent potentially curative liver resection for colorectal metastases. There were 64 males (66.7%) and 32 females (33.3%) with a median age of 60 years. There was no perioperative mortality. Postoperative morbidity was 7.2%. The median length of follow-up for the entire cohort of post hepatic resection was 29 months with 1-year and 3-year overall survival rates of 99% and 71%, respectively. The disease-free survival rates were 76% and 48%, respectively. Minor resections for the liver metastases showed significantly better overall survival. Primary tumour in the colon compared to rectum, disease-free interval (DFI) < 12 months and adjuvant chemotherapy showed a trend towards shorter overall survival. Carcinoembryonic antigen (CEA) levels greater than 100 ng/mL significantly shortens the disease-free survival.
CONCLUSION: Liver resection for colorectal metastases in our institution is a safe and effective treatment option in properly selected patients, which currently represents the best chance for long-term survival and possibly "cure".

Entities:  

Mesh:

Year:  2003        PMID: 12772523

Source DB:  PubMed          Journal:  Ann Acad Med Singapore        ISSN: 0304-4602            Impact factor:   2.473


  3 in total

1.  Giant cystic colorectal liver metastasis: an unusual presentation.

Authors:  A Y F Chung; C H K Chui; Y M Tan; B H Kwek; H W Tan; C H Thng; H C Toh
Journal:  Dig Dis Sci       Date:  2007-04-11       Impact factor: 3.199

Review 2.  Current preventive treatment for recurrence after curative hepatectomy for liver metastases of colorectal carcinoma: a literature review of randomized control trials.

Authors:  Peng Wang; Zhen Chen; Wen-Xia Huang; Lu-Ming Liu
Journal:  World J Gastroenterol       Date:  2005-07-07       Impact factor: 5.742

3.  Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors.

Authors:  Gena P Kanas; Aliki Taylor; John N Primrose; Wendy J Langeberg; Michael A Kelsh; Fionna S Mowat; Dominik D Alexander; Michael A Choti; Graeme Poston
Journal:  Clin Epidemiol       Date:  2012-11-07       Impact factor: 4.790

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.